Abstract
Purpose
Etidocaine (EDC) is a long lasting local anesthetic, which alleged toxicity has restricted its clinical use. Liposomes can prolong the analgesia time and reduce the toxicity of local anesthetics. Ionic gradient liposomes (IGL) have been proposed to increase the upload and prolong the drug release, from liposomes.
Methods
First, a HPLC method for EDC quantification was validated. Then, large unilamellar vesicles composed of hydrogenated soy phosphatidylcholine:cholesterol with 250 mM (NH4)2SO4 - inside gradient - were prepared for the encapsulation of 0.5% EDC. Dynamic light scattering, nanotracking analysis, transmission electron microscopy and electron paramagnetic resonance were used to characterize: nanoparticles size, polydispersity, zeta potential, concentration, morphology and membrane fluidity. Release kinetics and in vitro cytotoxicity tests were also performed.
Results
IGLEDC showed average diameters of 172.3 ± 2.6 nm, low PDI (0.12 ± 0.01), mean particle concentration of 6.3 ± 0.5 × 1012/mL and negative zeta values (−10.2 ± 0.4 mV); parameters that remain stable during storage at 4°C. The formulation, with 40% encapsulation efficiency, induced the sustained release of EDC (ca. 24 h), while reducing its toxicity to human fibroblasts.
Conclusion
A novel formulation is proposed for etidocaine that promotes sustained release and reduces its cytotoxicity. IGLEDC can come to be a tool to reintroduce etidocaine in clinical use.
Similar content being viewed by others
Abbreviations
- Cho:
-
Cholesterol
- DDS:
-
Drug delivery system
- DLS:
-
Dynamic light scattering
- EDC:
-
Etidocaine
- EPR:
-
Electron paramagnetic resonance
- HSPC:
-
Hydrogenated soy phosphatidylcholine
- IC50 :
-
Half maximal inhibitory concentration of cell viability
- IGL:
-
Ionic gradient liposomes
- IGLEDC :
-
Etidocaine-containing sulphate gradient liposomes
- LA:
-
Local anesthetic
- LUV:
-
Large unilamellar vesicle
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NTA:
-
Nanotracking analysis
- TEM:
-
Transmission electron microscopy
References
Wang G-K, Strichartz GR. State-dependent inhibition of sodium channels by local anesthetics: a 40-year evolution. Biochem (Mosc) Suppl Ser A Membr Cell Biol. 2012;6(2):120–7.
Lirk P, Picardi S, Hollmann MW. Local anaesthetics: 10 essentials. Eur J Anaesthesiol. 2014;31(11):575–85.
Strichartz GR, Sanchez V, Arthur GR, Chafetz R, Martin D. Fundamental properties of local anesthetics. II. Measured octanol: buffer partition coefficients and pKa values of clinically used drugs. Anesth Analg. 1990;71(2):158–70.
Covino BG, Vassalo HG. Local anesthetics: mechanisms of action and clinical use. Rio de Janeiro: Colina Editora; 1985.
Garciat DG. Etidocaine - a long-acting anesthestic agent: review of the literature. Anesth Prog. 1972;29(1):12–3.
Lund P, Cewik J, Gannon R. Etidocaine (Duranest®): a clinical and laboratory evaluation. Acta Anaesthesiol Scand Suppl. 1974;18(3):176–88.
Discontinued Drug Product List. US food and drug administration. Docket n° 2008-P-0527. September 25th, 2008. Available from: https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=N&Appl_No=017751. Acessed March 02, 2018.
Determination that Duranest® (etidocaine hydrochloride) injection, 0.5%, and five other Duranest® drug products were not withdrawn from sale for reasons of safety or effectiveness. FR. Federal Register / Vol. 77, No. 49 / March 13th, 2012 / Notices T. Vol. 77. 2012.
Allen T, Cullins P. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48.
Santamaria CM, Woodruff A, Yang R, Kohane DS. Drug delivery systems for prolonged duration local anesthesia. Mater Today. 2017;20(1):22–31.
Grant GJ, Barenholz Y, Piskoun B, Bansinath M, Turndorf H, Bolotin EM. DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice. Pharm Res. 2001;18(3):336–43.
de Paula E, Cereda CMS, Fraceto LF, de Araújo DR, Franz-Montan M, Tofoli GR, et al. Micro and nanosystems for delivering local anesthetics. Expert Opin Drug Deliv. 2012;9(12):1505–24.
Mura P, Capasso G, Maestrelli F, Furlanetto S. Optimization of formulation variables of benzocaine liposomes using experimental design. J Liposome Res. 2008;18(2):113–25.
Akbarzadeh A, Rezaei-sadabady R, Davaran S, Joo SW, Zarghami N. Liposome : classification, preparation, and applications. Nanoescale Res Lett. 2013;8(1):102.
da Silva CMG, Franz-Montan M, Limia CEG, Ribeiro LN de M, Braga MA, Guilherme VA, et al. Encapsulation of ropivacaine in a combined (donor-acceptor, ionic-gradient) liposomal system promotes extended anesthesia time. PLoS One. 2017;12(10):1–16.
Barenholz Y, Haran G. Method of amphiphatic drug loading in liposome by amonium ion gradient. US Patent. 1994;5:316–771.
Bolotin EM, Cohen R, Bar LK, Emanuel N, Ninio S, Barenholz Y, et al. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes. J Liposome Res. 1994;4(1):455–79.
Grant GJ, Barenholz Y, Bolotin EM, Bansinath M, Turndorf H, Piskoun B, et al. A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia. Anesthesiology. 2004;101(1):133–7.
Clerc S, Barenholz Y. Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. BBA - Biomembr. 1995;1240(2):257–65.
da Silva CMG, Fraceto LF, Franz-Montan M, Couto VM, Casadei BR, Cereda CMS, et al. Development of egg PC/cholesterol/α-tocopherol liposomes with ionic gradients to deliver ropivacaine. J Liposome Res. 2016;26(1):1–10.
de Paula E, Schreier S. Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure. Biochim Biophys Acta. 1995;1240(1):25–33.
ICH. Validation of analytical procedures: text and methodology Q2(R1). Geneva: Intl Conf. Harmon; 2005.
Tu S, Mcginnis T, Krugner-Higby L, Heath TD. A mathematical relationship for hydromorphone loading into liposomes with trans-membrane ammonium sulfate gradients. J Pharm Sci. 2010;99(6):2672–80.
Chen PS, Toribara TY, Warner H, Chen PS Jr, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem. 1956;28(11):1756–8.
Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470–5.
Zucker D, Marcus D, Barenholz Y, Goldblum A. Liposome drug’s loading efficiency: a working model based on loading conditions and drug’s physicochemical properties. J Control Release. 2009;139(1):73–80.
Hubbell WL, McConnell HM. Molecular motion in spin-labeled phospholipids and membranes. J Am Chem Soc. 1971;93(2):314–26.
Schreier S, Polnaszek CF, Smith I. Spin labels in membranes problems in practice. Biochim Biophys Acta. 1978;515(4):395–436.
Franz TJ. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol. 1975;64(3):190–5.
Mendyk A, Jachowicz R. Unified methodology of neural analysis in decision support systems built for pharmaceutical technology. Expert Syst Appl. 2007;32(4):1124–31.
Ribeiro LNM, Franz-Montan M, Breitkreitz MC, Alcântara ACS, Castro SR, Guilherme VA, et al. Nanostructured lipid carriers as robust systems for topical lidocaine-prilocaine release in dentistry. Eur J Pharm Sci. 2016;93:192–202.
Martinez EF, Araújo VC. In vitro immunoexpression of extracellular matrix proteins in dental pulpal and gingival human fibroblasts. Int Endod J. 2004;37(11):749–55.
Gasco MR. Lipid nanoparticles: perspectives and challenges. Adv Drug Deliv Rev. 2007;59(6):377–8.
Mohanraj V, Chen Y, Chen M. Nanoparticles – a review. Trop J Pharm Res Trop J Pharm Res. 2006;5(1):561–73.
Bhattacharjee S. DLS and zeta potential – what they are and what they are not? J Control Release. 2016;235:337–51.
Fraceto LF, Spisni A, Schreier S, de Paula E. Differential effects of uncharged aminoamide local anesthetics on phospholipid bilayers, as monitored by 1H-NMR measurements. Biophys Chem. 2005;115(1):11–8.
Ribeiro LNM, Couto VM, Fraceto LF, De Paula E. Use of nanoparticle concentration as a tool to understand the structural properties of colloids. Sci Rep. 2018;8(1):1–8.
Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. BBA - Biomembr. 1993;1151(2):201–15.
de Paula E, Schreier S, Jarrell HC, Fraceto LF. Preferential location of lidocaine and etidocaine in lecithin bilayers as determined by EPR, fluorescence and 2H NMR. Biophys Chem. 2008;132(1):47–54.
Gubernator J. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv. 2011;8(5):565–80.
Yeagle PL. The structure of biological membranes. 3rd ed. Boca Raton: CRC Rress; 2012.
Li J, Wang X, Zhang T, Wang C, Huang Z, Luo X, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci. 2014;10:81–98.
Zhong H, Deng Y, Wang X, Yang B. Multivesicular liposome formulation for the sustained delivery of breviscapine. Int J Pharm. 2005;301(1–2):15–24.
Grant SA. The holy grail: long-acting local anaesthetics and liposomes. Best Pract Res Clin Anaesthesiol. 2002;16(2):345–52.
Couto VM, Prieto MJ, Igartúa DE, Feas DA, Ribeiro LN, Silva CM, et al. Dibucaine in ionic-gradient liposomes: biophysical, toxicological and activity characterisation. J Pharm Sci. 2018;107:2411–9.
Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.
Malheiros SVP, Pinto LMA, Gottardo L, Yokaichiya DK, Fraceto LF, Meirelles NC, et al. A new look at the hemolytic effect of local anesthetics, considering their real membrane/water partitioning at pH 7.4. Biophys Chem. 2004;110(3):213–21.
Adade AB, Chignell D, Vanderkooi G. Local anesthetics: a new class of partial inhibitors of mitochondrial ATPase. J Bioenerg Biomembr. 1984;16(5–6):353–63.
Chang Y-C, Liu C-L, Chen M-J, Hsu Y-W, Chen S-N, Lin C-H, et al. Local anesthetics induce apoptosis in human breast tumor cells. Anesth Analg. 2014;118(1):116–24.
Torchilin VP. Interview with Vladimir P Torchilin: liposomal carriers for drug delivery. Ther Deliv. 2013;4(5):537–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oliveira, J.D., Ribeiro, L.N.d., Rodrigues da Silva, G.H. et al. Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity. Pharm Res 35, 229 (2018). https://doi.org/10.1007/s11095-018-2512-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11095-018-2512-4